Category Archives: Recalled Drugs

Featured Stories

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Class III Voluntary Recall Issued for High Blood Pressure Medication

Class III Recall Issued for High Blood Pressure Medication

As a result of a recent Enforcement Report of the U.S. Food and Drug Administration (FDA), Sun Pharma and Lupin  are recalling over 41.5 thousand drug bottles in the United States. Sun Pharmaceutical Industries Inc. is recalling 12,109 bottles of … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Teva Pharmaceuticals Initiates Voluntary Recall due to Potential Glass Particulate Matter

Teva Pharmaceuticals Initiates Voluntary Recall due to Glass

Teva Pharmaceuticals based in North Wales, Pennsylvania, announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL and 1 tram/4mL vials as a result of the potential presence of glass particulate matter. Amikacin Sulfate Injection is used … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Lawsuits Increasing in the US and Canada with Risks of Xarelto Use

The blood thinner Xarelto (rivaroxaban) is a relatively new anticoagulant that has gained popularity through its convenience of use for the patient. Warfarin, also known as Coumadin, the established anticoagulant for the last 60 years, requires dietary restrictions and a … Continue reading

Posted in Health Concerns, Recalled Drugs |

Children’s Cough Syrups Recalled Because of Incorrect Dosing Cup

cough-Syrup

Perrigo Company of Dublin, Ireland, has initiated a voluntary recall of five batches of its children’s cough syrups because some packages contain an oral dosing cup with incorrect dose markings and children could receive an overdose of the medicine. The … Continue reading

Posted in Health Concerns, Pharmaceuticals, Recalled Drugs | Tagged , , , , |

Florida Pharmacy Recalls Multivitamin Capsules that May Cause Vitamin D Toxicity

The Food and Drug Administration (FDA) has alerted health care providers and patients to a voluntary recall of compounded multivitamin capsules containing high amounts of vitamin D3 (cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. The FDA has received … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Infant Death Triggers FDA Warning About Probiotic Dietary Supplements

The Food and Drug Administration (FDA) has formally warned healthcare providers about using dietary supplements containing live bacteria or yeast in patients with compromised immune systems. The warning explains that dietary supplements are not regulated in the United States as approved … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Sun Pharmaceutical’s Effexor Recalled for the Second Time This Year

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor (venlafaxine), in the second recall of the drug this year, the Food and Drug Administration (FDA) said. In both instances, the recalled drug was manufactured at the Indian … Continue reading

Posted in Defective Products, Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA: All Non-Expired Sterile Unique Pharmaceuticals’ Drugs Recalled

The U.S. Food and Drug Administration (FDA) advised that it is alerting health care professionals and consumers regarding a recall of all non-expired drug products meant for sterile use and sold and distributed by Unique Pharmaceuticals Ltd., located in Temple, … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA Announces Recall of Generic Versions of Heart Drug Toprol XL

Just a few months after one generic version of a popular extended-release blood pressure medication was recalled, a lot of metoprolol succinate from another manufacturer was recalled for the same reason:  the drug did not dissolve properly. The recalled drugs, … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Indian Drugmaker Sun Pharma Recalls 400,000 Bottles of Two Drugs

Sun Pharma, India’s largest drugmaker, has announced the recall of almost 400,000 bottles of anti-depressant and antihistamine medications in the U.S. because the pills failed to dissolve properly. About 128,000 bottles of Sun Pharma’s antihistamine cetirizine, known by the brand … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.